This proposal will explore the mechanisms of regulation and signal transduction, as well as the pharmacology and physiological significance of dopamine (DA) neurons innervating the amygdaloid nuclear complex. Several hypotheses will be tested: 1) that there is a microheterogeneity of DA projection fields in the amygdaloid nuclear complex; 2) that mesoamygdaloid DA neurons exhibit characteristics of presynaptic regulation and postsynaptic signal transduction which are different from other DA systems; 3) that a subset of these populations of DA neurons fulfill criteria supporting their role in mediating the action of antipsychotic drugs, and in modulating the stress response mediated by amygdaloid mechanisms; and 4) that neurotensin (NT) is involved in the regulation and pharmacology of mesoamygdaloid DA neurons. Isolated explants of mesoamygdaloid DA neurons will be used to assess the role of impulse-regulating somatodendritic or release- regulating terminal autoreceptors. The DA receptor-mediated feedback activation of populations of mesoamygdaloid DA neurons will be examined as an additional regulatory variable. The topographic distribution of DA receptor subtypes, and their association with high affinity GTPase activity, specific GTP binding, and DARPP-32 or other DA and/or cAMP-regulated phosphoproteins in the amygdaloid complex will be mapped. Biochemical estimates of DA neuronal activity will be used to compare the administration of typical and atypical antipsychotic drugs. The response of mesoamygdaloid DA neurons to graded stress, distinct types of stressors, and the administration of carboline inverse agonists will be determined. The modulatory influence of NT on mesoamygdaloid DA neurons will be assessed using isolated neuronal explants and the site specific microinjection of fragments (Fab's) of NT antibodies. Immunoneutralization techniques will be further used to investigate the role of NT in the adaptive response of mesoamygdaloid DA neurons to chronic antipsychotic drug administration and their stress-induced activation. Quantitative autoradiographic techniques will be used to map the distribution and cellular localization of NT receptors in the amygdaloid complex. The effects of chronic antipsychotic drugs administration on the density and functional state of amygdaloid NT receptors will be determined.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
2R01MH039967-04A1
Application #
3377783
Study Section
Neurosciences Research Review Committee (BPN)
Project Start
1984-12-01
Project End
1993-11-30
Budget Start
1989-02-01
Budget End
1989-11-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Leonard, Sarah K; Anderson, Carl M; Lachowicz, Jean E et al. (2003) Amygdaloid D1 receptors are not linked to stimulation of adenylate cyclase. Synapse 50:320-33
Kilts, C D; Knight, D L; Nemeroff, C B (1996) The simultaneous determination of neurotensin and its major fragments by on-line trace enrichment HPLC with electrochemical detection. Life Sci 59:911-20
Dunn, L A; Atwater, G E; Kilts, C D (1993) Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioral model of clinical drug action. Psychopharmacology (Berl) 112:315-23
Scibilia, R J; Lachowicz, J E; Kilts, C D (1992) Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 11:146-54
Cain, S T; Bissette, G; Kilts, C D et al. (1992) A commentary on methods in peptide neurobiology: focus on neurotensin. Crit Rev Neurobiol 6:233-41
Coco, M L; Kuhn, C M; Ely, T D et al. (1992) Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam. Brain Res 590:39-47
Christison, G W; Atwater, G E; Dunn, L A et al. (1988) Haloperidol enhancement of latent inhibition: relation to therapeutic action? Biol Psychiatry 23:746-9
Kilts, C D; Anderson, C M; Ely, T D et al. (1988) The biochemistry and pharmacology of mesoamygdaloid dopamine neurons. Ann N Y Acad Sci 537:173-87
Kilts, C D; Anderson, C M; Bissette, G et al. (1988) Differential effects of antipsychotic drugs on the neurotensin concentration of discrete rat brain nuclei. Biochem Pharmacol 37:1547-54
Kilts, C D; Anderson, C M (1987) Mesoamygdaloid dopamine neurons: differential rates of dopamine turnover in discrete amygdaloid nuclei of the rat brain. Brain Res 416:402-8

Showing the most recent 10 out of 15 publications